Physician profile
Mark Scioli
NPI 1619971249
$70,079.51
in general payments reported to CMS, 2019-2025
35 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $9,816 · 2021: $6,827 · 2022: $9,513 · 2023: $13K · 2024: $3,885 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Royalty Or License: $11K · Travel and Lodging: $3,090 · Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,320.00 |
| Royalty Or License | $11,124.51 |
| Travel and Lodging | $3,090.25 |
| Food and Beverage | $2,344.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $48,102.71 | 2019-2025 | Aerial, Si-Lok, Excelsius Gps |
| 4web, INC. | $10,404.17 | 2019-2024 | Osteotomy Truss System |
| Ethicon INC. | $4,095.00 | 2023 | Stratafix |
| Spineology INC. | $2,831.34 | 2019-2025 | Optimesh Expandable Interbody Fusion System |
| Rattan and Associates | $1,324.94 | 2022-2025 | |
| Stryker Corporation | $613.28 | 2022-2025 | 7 X 23mm Citrelock Implant, Mako, Alphavent |
| Integra Lifesciences Corporation | $433.76 | 2019-2020 | |
| Si-Bone, INC. | $409.62 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $296.06 | 2019-2024 | Allogenix |
| Vertex Pharmaceuticals Incorporated | $139.50 | 2024-2025 | |
| Spineart USA INC | $132.61 | 2020-2021 | |
| Pacira Therapeutics, INC. | $125.23 | 2019-2021 | |
| Ets Wound Care LLC | $103.97 | 2025 | Mirragen Advanced Wound Matrix |
| Baudax Bio INC. | $102.67 | 2021-2022 | |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $87.77 | 2019 | |
| Amgen INC. | $86.02 | 2020-2024 | Evenity, Prolia |
| Ferring Pharmaceuticals INC. | $79.71 | 2019-2025 | Euflexxa |
| Nevro Corp. | $77.40 | 2024 | Senza |
| Bioventus LLC | $69.87 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Axogen | $61.93 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $55.60 | 2022-2025 | Exparel |
| Choice Spine, LLC | $52.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $52.03 | 2019-2022 | |
| Medtronic, INC. | $46.45 | 2023 | Corevalve Evolut R |
| Innovation Technologies INC | $44.00 | 2022-2023 | Irrisept |
| Merck Sharp & Dohme LLC | $23.80 | 2021-2022 | |
| Smith+Nephew, INC. | $21.75 | 2025 | Renasys Touch, Pico 14, Pico 7 |
| Mimedx Group, INC. | $18.67 | 2024 | |
| Lifenet Health | $18.60 | 2023 | |
| Biocomposites INC | $16.81 | 2025 | Stimulan |
| Depuy Synthes Sales INC. | $16.31 | 2023 | Monovisc |
| Ethicon US, LLC | $15.24 | 2020 | |
| Orthofix Medical, INC. | $13.32 | 2022 | |
| Heron Therapeutics, INC. | $5.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,547,852.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Scioli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.